Related Experiment Video
Updated: Aug 10, 2025

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Symptomatic subdural hemorrhage following heart valve surgery: a retrospective cohort study
Sotaro Oshida1, Junichi Tsuboi2, Hajime Kin2
1Departments of1Neurosurgery and.
Insights
Subdural hemorrhage (SDH) occurred in 2.0% of patients after heart valve surgery. Longer aortic clamp times, increased heparin dosage, and higher pulmonary artery pressure were linked to SDH development.
Area of Science:
- Neurosurgery
- Cardiovascular Surgery
- Neurology
Background:
- Subdural hemorrhage (SDH) is a known complication after open heart surgery.
- Clinical features and pathophysiology of SDH post-cardiac surgery require further elucidation.
Purpose of the Study:
- To determine the incidence and clinical course of symptomatic SDH after heart valve surgery.
- To identify factors associated with the development of SDH following heart valve surgery.
Main Methods:
- Retrospective review of 556 patients undergoing heart valve surgery with cardiopulmonary bypass (CPB).
- Analysis of preoperative cranial CT or MRI scans.
- Logistic regression analysis to identify associated factors.
Main Results:
- Symptomatic SDH occurred in 2.0% of patients, with onset 2-37 days post-surgery.
- 90.9% of SDH cases were located in the posterior fossa or occipital convexity.
- Longer aortic clamp time, higher post-operative heparin dose, and elevated pulmonary artery pressure (PAP) before CPB disconnection were significant risk factors.
Conclusions:
- The incidence of symptomatic SDH after heart valve surgery is 2.0%.
- SDH typically manifests within a month post-surgery, often in the posterior fossa or occipital regions.
- Key factors associated with SDH include prolonged aortic clamp time, increased heparin administration, and elevated PAP during CPB.
Objective:
Subdural hemorrhage (SDH) has been reported to be the most frequent intracranial hemorrhagic complication following open heart surgery; however, its clinical features and pathophysiology remain unclear. The aim of this retrospective study was to elucidate the incidence, clinical course, and factors associated with the development of symptomatic SDH following heart valve surgery.
Methods:
A retrospective review of medical records on the development of symptomatic SDH after heart valve surgery involving cardiopulmonary bypass (CPB) from April 2011 to March 2016 was performed. Patients who had undergone preoperative cranial computed tomography (CT) or brain magnetic resonance imaging (MRI) were included in this study, and factors associated with SDH following heart valve surgery were analyzed. When neurological symptoms developed after heart valve surgery, cranial CT or brain MRI was performed.
Results:
A total of 556 patients who had undergone heart valve surgery were analyzed. Among these patients, symptomatic SDH occurred in 11 (2.0%). The mean duration of symptomatic onset was 10.1 days (range 2-37 days). Ten of 11 patients (90.9%) developed SDH in the posterior fossa or occipital convexity. Logistic regression analysis revealed longer aortic clamp time (95% CI 1.00-1.10, p = 0.04), higher dose of heparin after surgery (95% CI 1.00-1.02, p = 0.001), and higher pulmonary artery pressure (PAP) just before disconnection of the CPB (95% CI 1.01-1.37, p = 0.04) as significantly associated with the development of SDH.
Conclusions:
The incidence of symptomatic SDH following heart valve surgery was 2.0%. Symptoms due to SDH usually developed a few days to 1 month after surgery. Surprisingly, most SDHs developed in the posterior fossa or occipital convexity following heart valve surgery. A longer aortic clamp time, higher dose of heparin after surgery, and higher PAP just before disconnection of the CPB were related to the development of symptomatic SDH following heart valve surgery.
More Related Videos
Related Concept Videos
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

